Fact CheckerSign in

NCT01932411Recruiting

Factors Affect Outcomes in Cardiovascular Surgery

Factors That Affect the Outcomes of Cardiothoracic and Vascular Surgery

Source: ClinicalTrials.gov · Last updated 14 Sept 2026

Brief summary (registry, in English)

Identify factors that contribute to perioperative morbidity and mortality in patients undergoing cardiac surgery that involves cardiopulmonary bypass. Identify factors that affect perioperative morbidity and mortality in patients undergoing cardiac surgery.

Status (registry)
Recruiting
Study type
Observational
Enrollment
5000 (estimated)
First submitted
27 Aug 2013
Start date
Jul 2013
Primary completion date
1 Dec 2026
Lead sponsor
University of California, Davis
NCT number
NCT01932411

What you commit to

  • Study type: Observational
  • Planned participants: 5000
  • From Jul 2013 to the primary completion date, 1 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • Patients that did not undergo cardiovascular surgeries and age\< 18 years old will be excluded from the study.

Who the study is looking for

  • Patients greater than or equal to 18 years old that underwent cardiovascular surgery at UC Davis Medical Center from 01/01/2001 to 07/15/2013.
  • Patients will only be included that underwent cardiovascular surgeries with or without cardiopulmonary bypass.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of California Davis Health System
Coordinator of this site? Confirm its status
SacramentoUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.